CEVA-102

N/A

Report date: 2025/05/14 14:16:38

Base Information

Drug NameCEVA-102
Drug Alias NameAutologous or allogeneic mechano-transduced cells (Cellvation)CEVA102
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Health Science Center At Houston
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellvation IncUniversity Of Texas Health Science Center At Houston
Active IndicationsN/A
Inactive IndicationsBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A